Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 26, 2022 - Issue 3
Submit an article Journal homepage
347
Views
2
CrossRef citations to date
0
Altmetric
Review

Emerging drug targets for colon cancer: A preclinical assessment

Madison M. Crutchera Departments of Surgery, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Trevor R. Baybuttb Departments of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Jessica S. Kopenhaverb Departments of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USAView further author information
,
Adam E. Snookb Departments of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA;c Departments of Microbiology & Immunology, Thomas Jefferson University, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0001-9216-4560View further author information
ORCID Icon &
Scott A. Waldmanb Departments of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USACorrespondence[email protected]
View further author information
Pages 207-216 | Received 07 Dec 2021, Accepted 03 Feb 2022, Published online: 10 Feb 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Madison M. Crutcher, Adam E. Snook & Scott A. Waldman. (2022) Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients. Expert Review of Clinical Pharmacology 15:11, pages 1317-1326.
Read now

Articles from other publishers (1)

Madison Crutcher & Scott Waldman. (2022) Biomarkers in the development of individualized treatment regimens for colorectal cancer. Frontiers in Medicine 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.